The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Management of the patient with eosinophilic asthma: a new era begins
Open accessAbstract
Now that it is generally accepted that asthma is a heterogeneous condition, phenotyping of asthma patients has become a mandatory part of the diagnostic workup of all patients who do not respond satisfactorily to standard therapy with inhaled corticosteroids. Late-onset eosinophilic asthma is currently one of the most well-defined asthma phenotypes and seems to have a different underlying pathobiology to classical childhood-onset, allergic asthma. Patients with this phenotype can be identified in the clinic by typical symptoms (few allergies and dyspnoea on exertion), typical lung function abnormalities (“fixed” airflow obstruction, reduced forced vital capacity and increased residual volume), typical comorbidities (nasal polyposis) and a good response to systemic corticosteroids. The definitive diagnosis is based on evidence of eosinophilia in bronchial biopsies or induced sputum, which can be estimated with reasonable accuracy by eosinophilia in peripheral blood. Until recently, patients with eosinophilic asthma had a very poor quality of life and many suffered from frequent severe exacerbations or were dependent on oral corticosteroids. Now, for the first time, novel biologicals targeting the eosinophil have become available that have been shown to be able to provide full control of this type of refractory asthma, and to become a safe and efficacious substitute for oral corticosteroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and clinical asthma phenotypes
Haldar, P., Pavord, I. D., Shaw, D. E., Berry, M. A., Thomas, M., Brightling, C. E., Wardlaw, A. J., & Green, R. H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1754oc · Cited by 1,987
Lambrecht, B. N., & Hammad, H. (2015) · Nature Immunology · doi:10.1038/ni.3049 · Cited by 1,673
Mjösberg, J. M., Trifari, S., Crellin, N. K., Peters, C. P., van Drunen, C. M., Piet, B., Fokkens, W. J., Cupedo, T., & Spits, H. (2011) · Nature Immunology · doi:10.1038/ni.2104 · Cited by 1,166
The cytokine network in asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36130 · Cited by 982
Enhanced innate type 2 immune response in peripheral blood from patients with asthma
Bartemes, K. R., Kephart, G. M., Fox, S. J., & Kita, H. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.06.024 · Cited by 390
Chronic sinusitis in severe asthma is related to sputum eosinophilia
ten Brinke, A., Grootendorst, D. C., Schmidt, J. T., de Bruïne, F. T., van Buchem, M. A., Sterk, P. J., Rabe, K. F., & Bel, E. H. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.122458 · Cited by 311
Self-citation
Cited by
Phenotypes and endotypes of adult asthma: Moving toward precision medicine
Kaur, R., & Chupp, G. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.05.031 · Cited by 457
McDonald, V. M., Fingleton, J., Agusti, A., Hiles, S. A., Clark, V. L., Holland, A. E., Marks, G. B., Bardin, P. P., Beasley, R., Pavord, I. D., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.02058-2018 · Cited by 317
Gans, M. D., & Gavrilova, T. (2020) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2019.08.002 · Cited by 306
Metadata
- Authors
- de Groot, J. C., ten Brinke, A., & Bel, E. H. D.
- Venue
- ERJ Open Research
- Publisher
- European Respiratory Society (ERS)
- Published
- 2015-05
- Volume
- 1
- Issue
- 1
- Pages
- 00024-2015
- ISSN
- 2312-0541 (ISSN-L)
- OpenAlex
- W2205538181
- Cited by
- 161
- References
- 6
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Management of the patient with eosinophilic asthma: a new era begins. https://app.cochat.ai/papers/10.1183/23120541.00024-2015
- The paper
- de Groot, J. C., ten Brinke, A., & Bel, E. H. D. (2015). Management of the patient with eosinophilic asthma: a new era begins. ERJ Open Research. https://doi.org/10.1183/23120541.00024-2015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.